Triple-negative breast cancer (TNBC) is a heterogenous subtype of breast cancer (BC) that is characterized by the lack of estrogen receptor, progesterone receptor expression, along with normal expression levels of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast cancer.